• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群、外泌体及其相互作用在酒精性肝病发病机制中的作用。

The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD.

作者信息

Cheng Zilu, Yang Ling, Chu Huikuan

机构信息

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei Province 430022, China.

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei Province 430022, China.

出版信息

J Adv Res. 2025 Jun;72:353-367. doi: 10.1016/j.jare.2024.07.002. Epub 2024 Jul 3.

DOI:10.1016/j.jare.2024.07.002
PMID:38969094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12147610/
Abstract

BACKGROUND

The liver disorders caused by alcohol abuse are termed alcoholic-related liver disease (ALD), including alcoholic steatosis, alcoholic steatohepatitis, alcoholic hepatitis, and alcoholic cirrhosis, posing a significant threat to human health. Currently, ALD pathogenesis has not been completely clarified, which is likely to be related to the direct damage caused by alcohol and its metabolic products, oxidative stress, gut dysbiosis, and exosomes.

AIMS

The existing studies suggest that both the gut microbiota and exosomes contribute to the development of ALD. Moreover, there exists an interaction between the gut microbiota and exosomes. We discuss whether this interaction plays a role in the pathogenesis of ALD and whether it can be a potential therapeutic target for ALD treatment.

KEY SCIENTIFIC CONCEPTS OF REVIEW

Chronic alcohol intake alters the diversity and composition of gut microbiota, which greatly contributes to ALD's progression. Some approaches targeting the gut microbiota, including probiotics, fecal microbiota transplantation, and phage therapy, have been confirmed to effectively ameliorate ALD in many animal experiments and/or several clinical trials. In ALD, the levels of exosomes and the expression profile of microRNA have also changed, which affects the pathogenesis of ALD. Moreover, there is an interplay between exosomes and the gut microbiota, which also putatively acts as a pathogenic factor of ALD.

摘要

背景

酒精滥用所致的肝脏疾病被称为酒精相关性肝病(ALD),包括酒精性脂肪变性、酒精性脂肪性肝炎、酒精性肝炎和酒精性肝硬化,对人类健康构成重大威胁。目前,ALD的发病机制尚未完全阐明,这可能与酒精及其代谢产物造成的直接损伤、氧化应激、肠道菌群失调和外泌体有关。

目的

现有研究表明,肠道微生物群和外泌体均参与ALD的发展。此外,肠道微生物群与外泌体之间存在相互作用。我们探讨这种相互作用是否在ALD的发病机制中起作用,以及它是否可以成为ALD治疗的潜在靶点。

综述的关键科学概念

长期饮酒会改变肠道微生物群的多样性和组成,这对ALD的进展有很大影响。一些针对肠道微生物群的方法,包括益生菌、粪便微生物群移植和噬菌体疗法,已在许多动物实验和/或一些临床试验中被证实可有效改善ALD。在ALD中,外泌体水平和微小RNA的表达谱也发生了变化,这影响了ALD的发病机制。此外,外泌体与肠道微生物群之间存在相互作用,这也可能是ALD的致病因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d4/12147610/1b774bd6bf60/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d4/12147610/430753668784/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d4/12147610/856814a077a2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d4/12147610/24ec1daebcc0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d4/12147610/89d307d24139/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d4/12147610/1b774bd6bf60/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d4/12147610/430753668784/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d4/12147610/856814a077a2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d4/12147610/24ec1daebcc0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d4/12147610/89d307d24139/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84d4/12147610/1b774bd6bf60/gr4.jpg

相似文献

1
The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD.肠道微生物群、外泌体及其相互作用在酒精性肝病发病机制中的作用。
J Adv Res. 2025 Jun;72:353-367. doi: 10.1016/j.jare.2024.07.002. Epub 2024 Jul 3.
2
Are Probiotics Effective in Targeting Alcoholic Liver Diseases?益生菌在靶向治疗酒精性肝病方面有效吗?
Probiotics Antimicrob Proteins. 2019 Jun;11(2):335-347. doi: 10.1007/s12602-018-9419-6.
3
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.粪便微生物群操作可预防小鼠的菌群失调和酒精性肝损伤。
J Hepatol. 2017 Apr;66(4):806-815. doi: 10.1016/j.jhep.2016.11.008. Epub 2016 Nov 25.
4
Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.靶向肠道微生物群治疗酒精性肝病:证据与前景
Acta Gastroenterol Belg. 2020 Oct-Dec;83(4):616-621.
5
Fecal microbiota transplantation from Helicobacter pylori carriers following bismuth quadruple therapy exacerbates alcohol-related liver disease in mice via LPS-induced activation of hepatic TLR4/NF-κB/NLRP3 signaling.铋剂四联疗法后幽门螺杆菌携带者的粪便微生物群移植通过脂多糖诱导的肝脏TLR4/NF-κB/NLRP3信号激活加重小鼠酒精性肝病。
J Transl Med. 2025 Jun 3;23(1):627. doi: 10.1186/s12967-025-06573-5.
6
The gut microbiota-produced vitamin B6 mitigates alcohol-associated liver disease by attenuating hepatic oxidative stress damage.肠道微生物群产生的维生素B6通过减轻肝脏氧化应激损伤来减轻酒精相关性肝病。
Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000599. eCollection 2025 Jan 1.
7
Microbiota-based treatments in alcoholic liver disease.基于微生物群的酒精性肝病治疗方法。
World J Gastroenterol. 2016 Aug 7;22(29):6673-82. doi: 10.3748/wjg.v22.i29.6673.
8
Alcohol or Gut Microbiota: Who Is the Guilty?酒精还是肠道微生物群:谁是罪魁祸首?
Int J Mol Sci. 2019 Sep 14;20(18):4568. doi: 10.3390/ijms20184568.
9
Gut Bacteria in Alcohol-Associated Liver Disease.肠道细菌与酒精性肝病。
Clin Liver Dis. 2024 Nov;28(4):663-679. doi: 10.1016/j.cld.2024.06.008. Epub 2024 Jul 24.
10
Alcohol, liver disease and the gut microbiota.酒精、肝病与肠道微生物组。
Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):235-246. doi: 10.1038/s41575-018-0099-1.

引用本文的文献

1
Dissecting the intratumoral microbiome landscape in lung cancer.剖析肺癌中的肿瘤内微生物群落景观。
Front Immunol. 2025 Jul 24;16:1614731. doi: 10.3389/fimmu.2025.1614731. eCollection 2025.
2
Nanoparticle-based therapeutic strategies for chronic liver diseases: Advances and insights.基于纳米颗粒的慢性肝病治疗策略:进展与见解
Liver Res. 2025 Apr 12;9(2):104-117. doi: 10.1016/j.livres.2025.04.002. eCollection 2025 Jun.
3
The Interplay Between Exosomes and Gut Microbiota in Neuroinflammation: A New Frontier in Alzheimer's Disease.

本文引用的文献

1
Combined analysis of 16S rDNA sequencing and metabolomics to find biomarkers of drug-induced liver injury.基于 16S rDNA 测序和代谢组学的联合分析寻找药物性肝损伤的生物标志物。
Sci Rep. 2023 Sep 13;13(1):15138. doi: 10.1038/s41598-023-42312-w.
2
Mesenchymal Stem Cell-Derived Exosomal miR-150-3p Affects Intracerebral Hemorrhage By Regulating TRAF6/NF-κB Axis, Gut Microbiota and Metabolism.间充质干细胞衍生的外泌体 miR-150-3p 通过调节 TRAF6/NF-κB 轴、肠道微生物群和代谢来影响脑出血。
Stem Cell Rev Rep. 2023 Aug;19(6):1907-1921. doi: 10.1007/s12015-023-10541-1. Epub 2023 Apr 26.
3
Perinatal tissue-derived exosomes ameliorate colitis in mice by regulating the Foxp3 + Treg cells and gut microbiota.
外泌体与肠道微生物群在神经炎症中的相互作用:阿尔茨海默病的新前沿
Int J Mol Sci. 2025 Jun 18;26(12):5828. doi: 10.3390/ijms26125828.
4
Gut microbiota in liver diseases: initiation, development and therapy.肝脏疾病中的肠道微生物群:起始、发展与治疗
Front Med (Lausanne). 2025 Jun 4;12:1615839. doi: 10.3389/fmed.2025.1615839. eCollection 2025.
5
The Role of Extracellular Vesicles in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Liver Diseases.细胞外囊泡在代谢功能障碍相关脂肪性肝病及其他肝脏疾病发病机制中的作用
Int J Mol Sci. 2025 May 23;26(11):5033. doi: 10.3390/ijms26115033.
6
Role of gut microbiota in thalassemia: a review of therapeutic prospects.肠道微生物群在地中海贫血中的作用:治疗前景综述
Front Physiol. 2025 Mar 19;16:1523448. doi: 10.3389/fphys.2025.1523448. eCollection 2025.
7
Exosomes in Precision Oncology and Beyond: From Bench to Bedside in Diagnostics and Therapeutics.精准肿瘤学及其他领域中的外泌体:从实验室到诊断与治疗的临床应用
Cancers (Basel). 2025 Mar 10;17(6):940. doi: 10.3390/cancers17060940.
胎组织来源的外泌体通过调节 Foxp3+Treg 细胞和肠道微生物群改善小鼠结肠炎。
Stem Cell Res Ther. 2023 Mar 20;14(1):43. doi: 10.1186/s13287-023-03263-1.
4
Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver disease.白色念珠菌特异性 Th17 细胞介导的反应有助于酒精相关性肝病。
Cell Host Microbe. 2023 Mar 8;31(3):389-404.e7. doi: 10.1016/j.chom.2023.02.001.
5
Exosome-Based Delivery of Super-Repressor IκBα Alleviates Alcohol-Associated Liver Injury in Mice.基于外泌体递送的超抑制因子IκBα减轻小鼠酒精性肝损伤
Pharmaceutics. 2023 Feb 14;15(2):636. doi: 10.3390/pharmaceutics15020636.
6
Effect of Ethanol on Exosome Biogenesis: Possible Mechanisms and Therapeutic Implications.乙醇对外泌体生成的影响:可能的机制和治疗意义。
Biomolecules. 2023 Jan 24;13(2):222. doi: 10.3390/biom13020222.
7
Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease.酒精相关性肝病发病机制的研究进展。
Annu Rev Pathol. 2023 Jan 24;18:411-438. doi: 10.1146/annurev-pathmechdis-031521-030435. Epub 2022 Oct 21.
8
Extracellular vesicle miRNAs promote the intestinal microenvironment by interacting with microbes in colitis.细胞外囊泡 miRNA 通过与结肠炎中的微生物相互作用促进肠道微环境。
Gut Microbes. 2022 Jan-Dec;14(1):2128604. doi: 10.1080/19490976.2022.2128604.
9
Probiotic ameliorate alcohol-induced hepatic damage gut microbial alteration.益生菌可改善酒精引起的肝损伤及肠道微生物改变。
Front Microbiol. 2022 Aug 18;13:869250. doi: 10.3389/fmicb.2022.869250. eCollection 2022.
10
Mesenchymal stem cell-derived exosome mitigates colitis the modulation of the gut metagenomics-metabolomics-farnesoid X receptor axis.间充质干细胞来源的外泌体减轻结肠炎 调节肠道宏基因组-代谢组学-法尼醇 X 受体轴。
Biomater Sci. 2022 Aug 24;10(17):4822-4836. doi: 10.1039/d2bm00559j.